Fig. 1From: Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)Time from first dose to second dose of study drug for a patients who were not pain free at 2 h and took a second dose of study drug or other migraine medication for rescue and b patients who were pain free at 2 h and took a second dose of study drug or other migraine medication for recurrenceBack to article page